Innovative Nanomaterials for Drug Delivery

A special issue of Micromachines (ISSN 2072-666X). This special issue belongs to the section "B:Biology and Biomedicine".

Deadline for manuscript submissions: closed (30 December 2022) | Viewed by 227

Special Issue Editor

Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA
Interests: drug delivery; lipid nanoparticles; gene editing; nanomedicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Nanomaterial-mediated drug delivery systems have been demonstrated to be advantageous for drug solubilization and stabilization, prolonging circulation time in blood, achieving organ- and tissue-specific delivery, facilitating cellular uptake, bypassing drug resistance mechanisms, etc. Naturally derived materials (e.g., exosomes, polysaccharides, and peptides and proteins) and synthetic materials (e.g., synthetic lipids, polymers, inorganic and hybrid nanoparticles) have been developed for the delivery of small molecule drugs, peptides and proteins (e.g., enzymes, antibodies, and hormones), and nucleic acids (e.g., plasmid DNA, mRNA, siRNA, miRNA, ASO). Nanomaterial-enabled drug delivery systems are being investigated extensively for a variety of therapeutic applications in oncology, infectious diseases, cardiovascular diseases, neurological diseases, autoimmune diseases, and many others. The safety and effectiveness of nanodrug delivery systems is closely associated with the physicochemical properties of carrier materials, including size, shape, chargeability, chemical composition, etc. Despite the great success that has been achieved in both fundamental research and clinical translations, there is a long-standing demand for the development of novel nanomaterials with new and better properties for drug delivery. Accordingly, this Special Issue seeks to showcase research papers, short communications, and review articles that focus on novel design, synthesis, characterization, and application of innovative nanomaterials for the delivery of therapeutic agents.

I look forward to receiving your submissions.

Dr. Yamin Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug delivery
  • nanomedicine
  • biomaterials
  • lipid nanomaterials
  • polymer nanomaterials
  • inorganic and hybrid nanomaterials
  • protein delivery
  • gene delivery

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop